RFK Jr. Plans to Restore Trust in HHS After COVID-19 Crisis

One year into Robert F. Kennedy Jr.’s tenure as Secretary of the US Department of Health and Human Services (HHS), a pattern has emerged: a sustained challenge to established public health norms and a corresponding erosion of trust in federal health agencies. Kennedy’s arrival at HHS coincided with a period of already diminished public confidence – a decline accelerated by the COVID-19 pandemic – and his actions since then have, according to many observers, deepened those concerns. Between April 2020 and September 2023, trust in the Centers for Disease Control and Prevention (CDC) as a source of information on coronavirus and vaccines fell from 83% to 63%.

A Shift in Vaccine Policy and the Legal Backlash

The most visible manifestation of this shift has been the controversy surrounding childhood vaccination schedules. In January 2026, the HHS and CDC announced a decision to remove universally recommended status from seven childhood vaccines. This move, swiftly met with legal opposition, is at the center of a multi-state lawsuit co-led by California, naming Kennedy Jr., HHS, the CDC and the CDC’s Director as defendants. Governor Gavin Newsom characterized the decision as a “reckless, unscientific childhood vaccine schedule” that ignores decades of medical evidence and risks outbreaks of preventable diseases. The lawsuit alleges that the changes circumvented federal laws and lacked solid scientific support.

The timing of this decision, and the legal challenge it provoked, underscores a broader trend: a willingness to question long-held scientific consensus on vaccine policy. The core argument from the states bringing the lawsuit centers on the idea that the federal government is overstepping its authority and endangering public health by deviating from evidence-based recommendations. This isn’t simply a disagreement over policy; it’s a fundamental dispute over the role of science in public health decision-making.

The Context of Eroding Trust

Kennedy Jr.’s appointment itself was viewed with skepticism by many in the public health community, given his long history of promoting unsubstantiated claims about vaccine safety. His background, initially as an environmental attorney focused on pollution’s impact on health, doesn’t align with traditional pathways to leadership within federal health agencies. While his early perform with Riverkeeper demonstrated a commitment to public service and environmental protection, his later advocacy on vaccine-related issues raised concerns about his scientific understanding and objectivity.

This pre-existing skepticism was exacerbated by the COVID-19 pandemic, which exposed vulnerabilities in public health communication and fueled the spread of misinformation. As the Associated Press reported, trust in US health agencies appears to be eroding, and Kennedy Jr. Is seen by some as actively reshaping U.S. Health policy in ways that further undermine that trust. The pandemic created a fertile ground for distrust, as rapidly evolving scientific understanding and political polarization collided, leaving many Americans unsure of who to believe.

What Does “Universally Recommended” Mean?

The shift away from “universally recommended” status for certain vaccines doesn’t necessarily mean these vaccines are no longer available or that the CDC advises against them. Instead, it signals a change in the agency’s guidance to healthcare providers. Previously, universally recommended vaccines were automatically included in routine childhood immunization schedules. Now, providers may need to make individual assessments based on a patient’s risk factors and local disease prevalence. This change, while potentially allowing for more personalized medicine, similarly introduces the possibility of inconsistent vaccination rates and increased vulnerability to outbreaks.

The Layoffs and Funding Cuts at HHS

Kennedy Jr. Inherited an HHS already facing significant challenges. In his first speech as Secretary, he acknowledged that the agency was grappling with devastating mass lay-offs and funding cuts. These cuts, largely driven by budgetary constraints and shifting political priorities, have hampered the agency’s ability to respond effectively to public health threats and maintain essential services. The simultaneous implementation of controversial policy changes, like the vaccine schedule revisions, has further strained morale and raised questions about the administration’s commitment to evidence-based public health.

Implications for Public Health Surveillance

A decline in vaccination rates, coupled with reduced funding for public health infrastructure, has significant implications for disease surveillance. Effective surveillance systems are crucial for detecting outbreaks early, tracking disease trends, and informing public health interventions. If vaccination rates fall and surveillance capabilities are weakened, the risk of preventable disease outbreaks increases substantially. This creates a vicious cycle: outbreaks erode public trust, leading to further declines in vaccination rates and further weakening of surveillance systems.

What Comes Next: A Procedural Outlook

The legal challenge to the CDC’s vaccine recommendations is likely to be protracted, potentially lasting for months or even years. The outcome of the lawsuit will have far-reaching consequences for public health policy and the relationship between the federal government and the states. Simultaneously, the HHS is expected to continue implementing its policy agenda, which includes a focus on “restoring trust” in public health agencies. Although, without a clear strategy for addressing the underlying causes of distrust – misinformation, political polarization, and a lack of transparency – it remains to be seen whether these efforts will be successful. The CDC and HHS will likely face continued scrutiny from Congress, the media, and the public, and their actions will be closely monitored for any further deviations from established scientific norms. Ongoing monitoring of vaccination rates and disease incidence will be critical for assessing the impact of these policy changes and informing future public health interventions.